Cargando…
Interleukin-1 receptor antagonist enhances chemosensitivity to fluorouracil in treatment of Kras mutant colon cancer
BACKGROUND: Kras mutant colon cancer shows abnormal activation of the nuclear factor kappa-B (NF-κB) pathway, resulting in the proliferation of tumor cells. Treatment with fluorouracil (5-FU) might not achieve the expected inhibition of proliferation of malignant cells based on the fluorouracil-indu...
Autores principales: | Yan, Yan, Lin, Hong-Wei, Zhuang, Zhuo-Nan, Li, Ming, Guo, Sen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443842/ https://www.ncbi.nlm.nih.gov/pubmed/32879665 http://dx.doi.org/10.4251/wjgo.v12.i8.877 |
Ejemplares similares
-
Hypoxia inducible factor 1α promotes interleukin-1 receptor antagonist expression during hepatic ischemia-reperfusion injury
por: Wang, Zhao-Yang, et al.
Publicado: (2022) -
Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma
por: Deng, Zhe, et al.
Publicado: (2021) -
Deltonin enhances gastric carcinoma cell apoptosis and chemosensitivity to cisplatin via inhibiting PI3K/AKT/mTOR and MAPK signaling
por: Yang, Lin, et al.
Publicado: (2023) -
Overexpression of CREPT confers colorectal cancer sensitivity to fluorouracil
por: Kuang, Yan-Shen, et al.
Publicado: (2018) -
Effects of mineralocorticoid receptor antagonists on responses to hemorrhagic shock in rats
por: Yamamoto, Kanako, et al.
Publicado: (2018)